Skip to content
CPHK
Toggle menu
  • Home
  • This is Us
    • History
    • Goals
    • Core Team
    • Leadership
    • Collaborative Hubs
  • Our Universe
    • Public Health Interests
    • Footprint
    • Research Collaborators
    • Areas of Work
    • Focus
  • Describing Us
    • Proficiencies
    • Approach
    • Projects Undertaken
      • India
      • Tanzania
    • Innovation & Impact
    • Supporting WHO
  • Universal Family
    • Partnerships
    • Funders & Donors
  • Resource Center
    • Publications
    • Workshops
    • Presentations
    • Top Citation
    • Gallery
    • Advertised Positions
  • Global Health
    • Lancet
    • Sci
    • NEJM
    • Tanzania
    • India
    • Global health update
  • Contact

Category: Uncategorized

February 25, 2022Uncategorized

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

Post Content

February 25, 2022Uncategorized

Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis

Post Content

February 25, 2022Uncategorized

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Post Content

February 25, 2022Uncategorized

The global COVID-19 treatment divide

Post Content

February 23, 2022Uncategorized

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of […]

February 22, 2022Uncategorized

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

COVID-19 vaccine efficacy or effectiveness against severe disease remained high, although it did decrease somewhat by 6 months after full vaccination. By […]

February 21, 2022Uncategorized

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

Post Content

February 21, 2022Uncategorized

Offline: A lie at the heart of public health

Post Content

February 21, 2022Uncategorized

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

All study vaccines boosted antibody and neutralising responses after ChAd/ChAd initial course and all except one after BNT/BNT, with no safety concerns. […]

February 21, 2022Uncategorized

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Post Content

Posts pagination

< 1 2 3 … 6 >

Recent Posts

  • [Action required] Your RSS.app Trial has Expired.
  • Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
  • Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
  • Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
  • The global COVID-19 treatment divide

Recent Comments

    Archives

    • March 2022
    • February 2022
    • October 2019

    Categories

    • Uncategorized
    • work

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent News

    • [Action required] Your RSS.app Trial has Expired. March 13, 2022
    • Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis February 26, 2022
    • Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial February 26, 2022

    Categories

    • Uncategorized
    • work

    Archives

    • March 2022
    • February 2022
    • October 2019

    Popular Tags

    CREATIVE IDEAS MUSIC PHOTOGRAPHY UNIQUE WORDPRESS TEMPLATE
    • Home
    • This is Us
    • Our Universe
    • Describing Us
    • Universal Family
    • Resource Center
    • Global Health
    • Contact
    © 2025 CPHK. Proudly powered by Sydney